Advertisements


Goldman Sachs Swaps Perrigo, Johnson & Johnson Ratings

The iShares Dow Jones US Healthcare (ETF) (NYSE: IYH) is up marginally year-to-date, but the profits aren’t bleeding into all health care constituents. Latest Ratings for JNJ .....»»

Category: blogSource: benzingaJul 12th, 2018

Microsoft, Goldman Sachs, IBM and More Dow Stocks to Watch This Week

What to expect from upcoming earnings reports from American Express, Johnson & Johnson, Microsoft and other Dow components......»»

Category: blogSource: 247wallstJul 15th, 2018

Johnson & Johnson upgraded to Neutral from Sell at Goldman Sachs

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 12th, 2018

Johnson & Johnson (JNJ) Presents at Goldman Sachs 39th Annual Global Healthcare Conference Call (Transcript)

Johnson & Johnson (JNJ) Presents at Goldman Sachs 39th Annual Global Healthcare Conference Call (Transcript).....»»

Category: topSource: seekingalphaJun 12th, 2018

Diageo shares rise 1.5% after ratings upgrade to buy from neutral at Goldman Sachs

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchJul 13th, 2018

Perrigo downgraded to Sell from Neutral at Goldman Sachs

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 12th, 2018

Goldman Sachs Cashes Out Of MGM Stock, Recommends Wyndham And Las Vegas Sands

For MGM Resorts International (NYSE: MGM), Las Vegas business hasn’t been booming the way some investors had hoped, prompting one Wall Street analyst to take a closer look at the stock. Latest Ratings for LVS .....»»

Category: blogSource: benzingaJun 26th, 2018

Goldman Sachs Steps To The Sidelines On AMC Networks, Cites Declining Ratings For "The Walking Dead"

The.....»»

Category: blogSource: benzingaJun 26th, 2018

Goldman Sachs: Mimecast Shares Have 20% Upside Potential

Mimecast Ltd (NASDAQ: MIME), an email and data security company, has endeared itself to an analyst at Goldman Sachs, who premised her positive opinion on three factors. Latest Ratings .....»»

Category: blogSource: benzingaJun 20th, 2018

Goldman Sachs Raises Netflix Price Target To $490, Projects Positive Cash Flow By 2022

One of Netflix, Inc. (NASDAQ: NFLX)'s biggest negatives is free cash flow, but it's a concern that will subside as the company exits 2018, according t Latest Ratings fo.....»»

Category: blogSource: benzingaJun 13th, 2018

Cigna Set To Disrupt Commercial Risk Market, Goldman Sachs Says In Upgrade

Insurer CIGNA Corporation (NYSE: CI) is poised to sustain share gains in the U.S. commercial risk market, according to Goldman Sachs. Latest Ratings for C.....»»

Category: blogSource: benzingaJun 6th, 2018

Ulta Beauty Downgraded By Goldman Sachs As Loyalty Program Growth Slows

Ulta Beauty Inc (NASDAQ: ULTA) risk-reward scenario appears more balanced following the stock’s recent recovery, according to a new report from Goldman Sachs. Latest Ratings for ULTA Date.....»»

Category: blogSource: benzingaJun 5th, 2018

Goldman: Not All Metal And Mining Stocks Are Created Equal

The ability of metal and mining companies to translate positive market conditions into healthy financial performance aren't universal, according to Goldman Sachs.  Latest Ratings for AKS Date.....»»

Category: blogSource: benzingaMay 30th, 2018

From Laggard To Leader: Goldman Initiates Ceridian At Neutral

The Ceridian HCM Holding Inc (NYSE: CDAY) story is one of transformation from a human capital management “laggard” to cloud “leader,” according to Goldman Sachs. Latest Ratings for CDAY Da.....»»

Category: blogSource: benzingaMay 21st, 2018

Goldman Presses Sell Button On Avnet On Incremental Risk To Semi Cycle

Avnet, Inc. (NASDAQ: AVT), a distributor of electronic components and embedded solutions, is likely to be plagued by margin pressure and challenging semiconductor industry cycle, according to an analyst at Goldman Sachs. Latest Ratings .....»»

Category: blogSource: benzingaMay 16th, 2018

Goldman Sachs Considers Ollie"s A Bargain, Initiates With A Buy Rating

Ollie’s Bargain Outlet Holdings Inc (NASDAQ: OLLI) has consistently beat earnings and demonstrated resilience amid an expanding e-commerce scene. Goldman Sachs thinks its rise is just beginning. Latest Ratings for OLLI .....»»

Category: blogSource: benzingaMay 16th, 2018

Vertical Group"s Gordon Johnson Figures Tesla Lost $15K Per Model 3 In Q1

Each Model 3 sold in the first quarter of this year cost Tesla Inc (NASDAQ: TSLA) nearly $14,000, according to calculations by Vertical Group’s Gordon Johnson. Latest Ratings for TSLA .....»»

Category: blogSource: benzingaMay 9th, 2018

Goldman Sachs BDC Positioned For Dividend Increase, Says Raymond James

Goldman Sachs BDC, Inc. (NYSE: GSBD) is positioned to grow its dividend, while plans to increase leverage and lower management fees provide a “win, win” situation, according to Raymond James. Latest Ratings for GSBD DateFi.....»»

Category: blogSource: benzingaMay 7th, 2018

Citrix Added to Goldman Sachs" Conviction List Ahead Of Analyst Day

SaaS provider Citrix Systems, Inc. (NASDAQ: CTXS) was added to Goldman's America's Conviction List ahead of its Tuesday, May 8 analyst day.  Latest Ratings for CTXS .....»»

Category: blogSource: benzingaMay 1st, 2018

Despite "Challenging" Economics, Goldman Sachs Is Bullish On Spotify

Streaming music provider Spotify Technology SA (NYSE: SPOT) is the leader in the online music space and has plenty of room for further growth ahead, according to Goldman Sachs. Latest Ratings for SPOT Dat.....»»

Category: blogSource: benzingaApr 30th, 2018

Goldman Sachs Neutral On Alder Biopharma As Launch Of Migraine Treatment Approaches

Before Tuesday, 90 percent of Alder Biopharmaceuticals Inc (NASDAQ: ALDR) analysts were buying the stock. But one analyst has diluted the decisive bullishness with rare ambivalence. Latest Ratings for ALDR DateF.....»»

Category: blogSource: benzingaApr 24th, 2018